Paper41007646
Editorial for the Special Issue "Anticancer Activity and Metabolic Pathways of Natural Products 2.0".
Baek SH. Biomedicines, 2025. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Editorial for the Special Issue "Anticancer Activity and Metabolic Pathways of Natural Products 2.0". Papers, record 41007646. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41007646
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Editorial for the Special Issue "Anticancer Activity and Metabolic Pathways of Natural Products 2.0".
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References13
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 34195085 | Targeting Growth Factor Signaling Pathways in Pancreatic Cancer: Towards Inhibiting Chemoresistance. | Front Oncol | 2021 | https://conductscience.org/library/papers/34195085 | PubMed |
| 2 | 35453310 | Hyperthermia Treatment as a Promising Anti-Cancer Strategy: Therapeutic Targets, Perspective Mechanisms and Synergistic Combinations in Experimental Approaches. | Antioxidants (Basel) | 2022 | https://conductscience.org/library/papers/35453310 | PubMed |
| 3 | 36289647 | The SIRT2 Pathway Is Involved in the Antiproliferative Effect of Flavanones in Human Leukemia Monocytic THP-1 Cells. | Biomedicines | 2022 | https://conductscience.org/library/papers/36289647 | PubMed |
| 4 | 28246180 | TGF-β Family Signaling in Tumor Suppression and Cancer Progression. | Cold Spring Harb Perspect Biol | 2017 | https://conductscience.org/library/papers/28246180 | PubMed |
| 5 | 37107299 | Combination Therapy of Radiation and Hyperthermia, Focusing on the Synergistic Anti-Cancer Effects and Research Trends. | Antioxidants (Basel) | 2023 | https://conductscience.org/library/papers/37107299 | PubMed |
| 6 | 34663943 | The manipulation of apoptosis for cancer therapy using BH3-mimetic drugs. | Nat Rev Cancer | 2022 | https://conductscience.org/library/papers/34663943 | PubMed |
| 7 | 32872198 | Combination Therapy with Cinnamaldehyde and Hyperthermia Induces Apoptosis of A549 Non-Small Cell Lung Carcinoma Cells via Regulation of Reactive Oxygen Species and Mitogen-Activated Protein Kinase Family. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/32872198 | PubMed |
| 8 | 35022204 | Hallmarks of Cancer: New Dimensions. | Cancer Discov | 2022 | https://conductscience.org/library/papers/35022204 | PubMed |
| 9 | 36289922 | Inflammation Related to Obesity in the Etiopathogenesis of Gastroenteropancreatic Neuroendocrine Neoplasms. | Biomedicines | 2022 | https://conductscience.org/library/papers/36289922 | PubMed |
| 10 | 29747682 | The biology and role of CD44 in cancer progression: therapeutic implications. | J Hematol Oncol | 2018 | https://conductscience.org/library/papers/29747682 | PubMed |
| 11 | 34753495 | BH3-mimetics: recent developments in cancer therapy. | J Exp Clin Cancer Res | 2021 | https://conductscience.org/library/papers/34753495 | PubMed |
| 12 | 38790669 | Inhibiting AGS Cancer Cell Proliferation through the Combined Application of Aucklandiae Radix and Hyperthermia: Investigating the Roles of Heat Shock Proteins and Reactive Oxygen Species. | Antioxidants (Basel) | 2024 | https://conductscience.org/library/papers/38790669 | PubMed |
| 13 | 37972575 | Inhibition of transforming growth factor-β signals suppresses tumor formation by regulation of tumor microenvironment networks. | Cancer Sci | 2024 | https://conductscience.org/library/papers/37972575 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 41201023 | Dihydroalterperylenol from endophytic fungus Alternaria semiverrucosa and its antitumour activity uncovered by transcriptome analysis, molecular docking and molecular dynamics simulations. | Mol Med Rep | 2026 | https://conductscience.org/library/papers/41201023 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41007646
GET https://conductscience.org/api/papers/v1/41007646/authors